Country: United States
Language: English
Source: NLM (National Library of Medicine)
ACYCLOVIR (UNII: X4HES1O11F) (ACYCLOVIR - UNII:X4HES1O11F)
Ranbaxy Laboratories Ltd.
ACYCLOVIR
ACYCLOVIR 200 mg
ORAL
PRESCRIPTION DRUG
Herpes Zoster Infections: Acyclovir capsules, USP and acyclovir tablets, USP are indicated for the acute treatment of herpes zoster (shingles). Genital Herpes: Acyclovir capsules, USP and acyclovir tablets, USP are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox: Acyclovir capsules, USP and acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella). Acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.
Acyclovir capsules, USP (white, opaque cap and body) containing 200 mg acyclovir, USP and printed with “RX 652 ” on both the cap and the body. Bottle of 50 (NDC 63304-652-50) Bottle of 100 (NDC 63304-652-01) Bottle of 500 (NDC 63304-652-05) Bottle of 1000 (NDC 63304-652-10) Acyclovir tablets, USP (white, oval-shaped, unscored) containing 800 mg acyclovir, USP and debossed with “RX 505 ” on one side. Bottle of 50 (NDC 63304-505-50) Bottle of 100 (NDC 63304-505-01) Bottle of 180 (NDC 63304-505-28) Acyclovir tablets, USP (white, oval-shaped, unscored) containing 400 mg acyclovir, USP and debossed with “RX 504 ” on one side. Bottle of 50 (NDC 63304-504-50) Bottle of 100 (NDC 63304-504-01) Bottle of 180 (NDC 63304-504-28) Store at 20 - 25° C (68 - 77° F) [See USP Controlled Room Temperature]. Protect from moisture. You may report side effects to FDA at 1-800-FDA-1088. Manufactured for: Ranbaxy Pharmaceuticals Inc. Jacksonville, FL 32257 USA by: Ohm Laboratories Inc. North Brunswick, NJ 08902 USA July 2009
Abbreviated New Drug Application
ACYCLOVIR- ACYCLOVIR CAPSULE ACYCLOVIR- ACYCLOVIR TABLET RANBAXY LABORATORIES LTD. ---------- ACYCLOVIR CAPSULES, USP AND ACYCLOVIR TABLETS, USP RX ONLY DESCRIPTION Acyclovir is a synthetic nucleoside analogue active against herpes viruses. Acyclovir capsules, USP and acyclovir tablets, USP are formulations for oral administration. Each capsule of acyclovir contains 200 mg of acyclovir, USP and the inactive ingredients lactose monohydrate, magnesium stearate, and pregelatinized starch. The capsule shell consists of gelatin and titanium dioxide, printed with edible printing ink that contains black iron oxide, and propylene glycol. Each 800 mg tablet of acyclovir contains 800 mg of acyclovir, USP and the inactive ingredients colloidal silicone dioxide, magnesium stearate, microcrystalline cellulose, pregelatinized starch, and sodium starch glycolate. Each 400 mg tablet of acyclovir contains 400 mg of acyclovir, USP and the inactive ingredients colloidal silicone dioxide, magnesium stearate, microcrystalline cellulose, pregelatinized starch, and sodium starch glycolate. Acyclovir, USP is a white to off-white crystalline powder with the molecular formula C H N O and a molecular weight of 225. The maximum solubility in water at 37°C is 2.5 mg/mL. The pka’s of acyclovir are 2.27 and 9.25. The chemical name of acyclovir is 2-amino-1, 9-dihydro-9- [(2-hydroxyethoxy)methyl]-6_H_-purin-6-one; it has the following structural formula: VIROLOGY MECHANISM OF ANTIVIRAL ACTION: Acyclovir is a synthetic purine nucleoside analogue with _in vitro _and _in vivo _inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella-zoster virus (VZV). The inhibitory activity of acyclovir is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts acyclovir into acyclovir monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzyme Read the complete document